Genomic sequencing and genetic medicines & therapeutics are helping transform health care in key areas with growing demand, including drug development, precision medicine, and more.
Limit company-specific risks, such as risk of testing failures or higher than anticipated development costs, by using an equal weighting across many biotechnology companies.
CURE provides global exposure to emerging areas within the Health Care sector, at the intersection of science and technology.
Inception Date | 8 Nov 2018 |
Management Costs (% p.a.) | 0.45 |
Currency Hedged | No |
Domicile | Australia |
Legal Form | Managed Investment Scheme |
SMSF Eligible | Yes |
NAV/Unit (A$) | 47.35900000 |
Currency (NAV) | AUD |
Shares Outstanding | 844,012 |
AUM (A$) | 39,971,529.57 |
NAV History File | View |
The Global X S&P Biotech ETF (CURE) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology.
The Global X S&P Biotech ETF (CURE) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the S&P Biotechnology Select Industry Index.
Ticker | CURE |
Bloomberg Code | CURE AU Equity |
ISIN | AU0000028110 |
Trading Hours | 10:00AM – 4:00PM |
Issuer | Global X Management (AUS) Limited |
Custodian | The Hongkong and Shanghai Banking Corporation Limited, Sydney Branch |
Registrar | Computershare Investor Services Pty Limited |
Benchmark | S&P Biotechnology Select Industry Index |
Provider | S&P Indices |
Ticker | SPSIBIN |
12-Month Yield | 0.00% |
12-Month Franking Level | 0.00% |
Distribution Frequency | Annually |
Distribution History | View |
Total Return (Fund) | Total Return (Benchmark) | Tracking Difference | Tracking Error | |
---|---|---|---|---|
1 Month | 3.69% | 3.76% | -0.07% | 0.03% |
3 Months | -2.99% | -2.83% | -0.16% | 0.37% |
1 Year | 8.40% | 9.28% | -0.87% | 0.54% |
3 Year p.a. | -5.45% | -5.15% | -0.30% | 1.00% |
5 Year p.a. | 2.49% | 2.90% | -0.42% | 0.86% |
10 Year p.a. | -- | -- | -- | -- |
Since Inception p.a. | 3.10% | 3.53% | -0.43% | 0.84% |
Net Assets (%) | Name | SEDOL | Market Price (Local) | Shares Held | Market Value (A$) |
---|---|---|---|---|---|
2.74 | NOVAVAX INC | BJDQXG4 | 14.40 | 50,838 | 1,096,483 |
1.73 | ALPINE IMMUNE SC | BYX38M1 | 64.96 | 7,088 | 689,638 |
1.34 | MODERNA INC | BGSXTS3 | 132.68 | 2,689 | 534,377 |
1.29 | TWIST BIOSCIENCE | BGKG6G7 | 46.50 | 7,375 | 513,649 |
1.27 | CRINETICS PHARMA | BDD19F8 | 51.91 | 6,552 | 509,420 |
1.26 | NATERA INC | BYQRG48 | 108.50 | 3,111 | 505,570 |
1.26 | REVOLUTION MEDIC | BL71K91 | 38.99 | 8,591 | 501,705 |
1.20 | BLUEPRINT MEDICI | BWY52P3 | 106.64 | 3,002 | 479,493 |
1.19 | AMGEN INC | 2023607 | 314.72 | 1,012 | 477,041 |
1.16 | UNITED THERAPEUT | 2430412 | 272.22 | 1,140 | 464,811 |
1.15 | BIOCRYST PHARM | 2100362 | 6.47 | 47,427 | 459,601 |
1.15 | IMMUNITYBIO INC | BNSP0B8 | 7.75 | 39,590 | 459,556 |
1.13 | PTC THERAPEUTICS | B17VCN9 | 34.03 | 8,892 | 453,224 |
1.13 | HALOZYME THERAPE | 2975098 | 45.39 | 6,639 | 451,351 |
1.12 | DYNE THERAPEUTIC | BN15WD1 | 28.75 | 10,405 | 448,055 |
1.11 | BRIDGEBIO PHARMA | BK1KWG8 | 31.04 | 9,561 | 444,505 |
1.11 | ROIVANT SCIENCES | BMW4NZ9 | 11.41 | 25,942 | 443,343 |
1.11 | SAREPTA THERAPEU | B8DPDT7 | 132.74 | 2,228 | 442,964 |
1.11 | VERTEX PHARM | 2931034 | 440.64 | 670 | 442,191 |
1.08 | TG THERAPEUTICS | B828K63 | 17.42 | 16,512 | 430,823 |
1.08 | VAXCYTE INC | BKPVGH6 | 75.45 | 3,812 | 430,788 |
1.07 | BIOGEN INC | 2455965 | 230.04 | 1,241 | 427,589 |
1.07 | CEREVEL THERAPEU | BMVMJ12 | 42.35 | 6,717 | 426,069 |
1.06 | GERON CORP | 2370381 | 3.90 | 72,849 | 425,539 |
1.06 | NEUROCRINE BIOSC | 2623911 | 141.91 | 1,990 | 422,977 |
1.05 | ALNYLAM PHARMACE | B00FWN1 | 151.22 | 1,849 | 418,791 |
1.04 | REGENERON PHARM | 2730190 | 967.98 | 286 | 414,652 |
1.03 | IMMUNOVANT INC | BJRFSB7 | 31.48 | 8,743 | 412,236 |
1.00 | VIKING THERAPEUT | BQQG1V1 | 69.06 | 3,860 | 399,268 |
1.00 | DENALI THERAPEUT | BD2B4V0 | 20.24 | 13,140 | 398,343 |
0.99 | EXELIXIS INC | 2576941 | 21.23 | 12,475 | 396,681 |
0.99 | KRYSTAL BIOTECH | BD6JX35 | 163.78 | 1,612 | 395,437 |
0.98 | INCYTE CORP | 2471950 | 56.86 | 4,616 | 393,119 |
0.97 | RHYTHM PHARMACEU | BF2YWG4 | 39.17 | 6,606 | 387,564 |
0.95 | ABBVIE INC | B92SR70 | 164.35 | 1,549 | 381,305 |
0.95 | IDEAYA BIOSCIENC | BK0VHF6 | 41.53 | 6,081 | 378,258 |
0.95 | CYTOKINETICS INC | BBBSBJ5 | 59.92 | 4,214 | 378,196 |
0.94 | GILEAD SCIENCES | 2369174 | 67.86 | 3,688 | 374,849 |
0.94 | INSMED INC | 2614487 | 25.10 | 9,959 | 374,404 |
0.93 | ARDELYX INC | BN89V40 | 7.79 | 31,883 | 372,004 |
0.93 | BIOMARIN PHARMAC | 2437071 | 76.97 | 3,224 | 371,679 |
0.93 | VERICEL CORP | BSBMN89 | 47.61 | 5,207 | 371,310 |
0.91 | SPRINGWORKS THER | BGMGM89 | 44.77 | 5,425 | 363,779 |
0.91 | INTELLIA THERAPE | BYZM6C2 | 26.17 | 9,245 | 362,378 |
0.90 | CATALYST PHARMAC | B1G7Q03 | 16.40 | 14,707 | 361,259 |
0.90 | EXACT SCIENCES | 2719951 | 51.95 | 4,615 | 359,094 |
0.89 | NUVALENT INC-A | BMVBZD3 | 72.64 | 3,283 | 357,189 |
0.89 | DYNAVAX TECHNOLO | BRJZSK0 | 11.28 | 21,086 | 356,250 |
0.89 | ALTIMMUNE INC | BFY7DC4 | 8.90 | 26,666 | 355,467 |
0.89 | IONIS PHARMACEUT | BDJ0LS6 | 37.62 | 6,298 | 354,873 |
0.88 | SYNDAX PHARMACEU | BN7Q7R7 | 20.92 | 11,277 | 353,351 |
0.88 | MADRIGAL PHARMAC | BD59BS7 | 217.17 | 1,085 | 352,924 |
0.88 | RECURSION PHAR-A | BM9FJ13 | 9.51 | 24,760 | 352,681 |
0.88 | AGIOS PHARMACEUT | BCBVTX1 | 35.00 | 6,683 | 350,341 |
0.88 | ULTRAGENYX PHARM | BJ62Z18 | 42.61 | 5,483 | 349,930 |
0.87 | ROCKET PHARMACEU | BDFKQ07 | 23.40 | 9,941 | 348,415 |
0.87 | ALKERMES PLC | B3P6D26 | 24.46 | 9,472 | 347,016 |
0.87 | CELLDEX THERAPEU | BJLV8T9 | 39.94 | 5,783 | 345,949 |
0.86 | PROTAGONIST THER | BDCBCD8 | 31.94 | 7,227 | 345,736 |
0.85 | KYMERA THERAPEUT | BMPRZV5 | 35.60 | 6,371 | 339,710 |
0.85 | ARCUTIS BIOTHERA | BKX9VD3 | 9.12 | 24,849 | 339,434 |
0.83 | VERA THERAPEUTIC | BL55460 | 41.94 | 5,281 | 331,738 |
0.82 | VERACYTE INC | BFTWZY0 | 23.40 | 9,322 | 326,720 |
0.81 | MORPHIC HOLDING | BK8M4J4 | 32.45 | 6,671 | 324,233 |
0.81 | KURA ONCOLOGY IN | BYZD465 | 22.98 | 9,404 | 323,678 |
0.80 | PROTHENA CORP PL | B91XRN2 | 23.39 | 9,168 | 321,186 |
0.80 | AMICUS THERAPEUT | B19FQ48 | 9.50 | 22,526 | 320,523 |
0.79 | INHIBRX INC | BK1MBC3 | 34.49 | 6,102 | 315,222 |
0.78 | ARROWHEAD PHARMA | BYQBFJ8 | 25.00 | 8,283 | 310,155 |
0.77 | IRONWOOD PHARMAC | B3MZ6K5 | 6.64 | 30,751 | 305,829 |
0.76 | ARCELLX INC | BPCJ1Q2 | 52.79 | 3,830 | 302,832 |
0.75 | MIRUM PHARMACEUT | BJDX8Y8 | 24.75 | 8,045 | 298,231 |
0.73 | CRISPR THERAPEUT | BDHF4K6 | 55.67 | 3,511 | 292,754 |
0.73 | KEROS THERAPEUTI | BM7V485 | 53.99 | 3,611 | 292,006 |
0.71 | APELLIS PHARMACE | BYTQ6X1 | 42.00 | 4,496 | 282,831 |
0.70 | ADMA BIOLOGICS I | B9NSBM2 | 9.06 | 20,613 | 279,718 |
0.69 | MYRIAD GENETICS | 2614153 | 24.61 | 7,529 | 277,524 |
0.69 | BIOMEA FUSION IN | BNKF6N0 | 12.78 | 14,453 | 276,656 |
0.69 | AKERO THERAPEUTI | BK7Y2V9 | 20.73 | 8,886 | 275,903 |
0.69 | IOVANCE BIOTHERA | BF0DMK7 | 10.43 | 17,647 | 275,681 |
0.69 | BIOHAVEN LTD | BPLZ7S5 | 38.45 | 4,779 | 275,223 |
0.68 | VIRIDIAN THERAPE | BMDH2B6 | 14.63 | 12,354 | 270,709 |
0.67 | ARCUS BIOSCIENCE | BDZT9Y9 | 17.46 | 10,262 | 268,366 |
0.66 | BEAM THERAPEUTIC | BK6L288 | 23.79 | 7,382 | 263,039 |
0.66 | ACADIA PHARMACEU | 2713317 | 14.85 | 11,820 | 262,903 |
0.65 | AVIDITY BIOSCIEN | BMWHPY1 | 28.72 | 6,072 | 261,197 |
0.63 | DECIPHERA PHARMA | BZ1LFB2 | 25.45 | 6,593 | 251,317 |
0.61 | CAREDX INC | BP3YM74 | 14.78 | 11,021 | 243,976 |
0.60 | COGENT BIOSCIENC | BLR6XK8 | 7.47 | 21,296 | 238,270 |
0.58 | XENCOR INC | BGCYWN8 | 22.46 | 6,930 | 233,128 |
0.56 | C4 THERAPEUTICS | BKX9NQ0 | 5.97 | 25,188 | 225,226 |
0.56 | SCHOLAR ROCK HOL | BFZQ0L8 | 14.32 | 10,446 | 224,050 |
0.55 | SOLENO THERAPEUT | BL6JK96 | 45.66 | 3,207 | 219,324 |
0.55 | AVID BIOSERVICES | BFMZ4W7 | 9.20 | 15,879 | 218,807 |
0.54 | ARCTURUS THERAPE | BKC9SX3 | 30.50 | 4,731 | 216,124 |
0.54 | EDITAS MEDICINE | BZ8FPH3 | 5.89 | 24,348 | 214,798 |
0.53 | SAGE THERAPEUTIC | BP4GNK9 | 12.01 | 11,856 | 213,271 |
0.51 | CABALETTA BIO IN | BK5MWR1 | 12.62 | 10,708 | 202,404 |
0.49 | VIR BIOTECHNOLOG | BK4PZ38 | 9.93 | 13,273 | 197,410 |
0.49 | REPLIMUNE GROUP | BDDVW37 | 6.72 | 19,399 | 195,254 |
0.48 | SANA BIOTECHNOLO | BMFJJ97 | 8.55 | 14,983 | 191,874 |
0.47 | 89BIO INC | BK1K484 | 8.97 | 13,957 | 187,515 |
0.45 | 4D MOLECULAR THE | BKLXFX5 | 25.64 | 4,700 | 180,496 |
0.45 | TRAVERE THERAPEU | BLFGJD5 | 6.69 | 17,983 | 180,194 |
0.40 | ZENTALIS PHARMAC | BMQ5T49 | 11.96 | 9,004 | 161,294 |
0.40 | APOGEE THERAPEUT | BM9HHL5 | 53.75 | 1,998 | 160,851 |
0.38 | MANNKIND CORP | BF081J4 | 4.59 | 22,119 | 152,065 |
0.37 | DISC MEDICINE IN | BMGJZJ8 | 31.92 | 3,108 | 148,592 |
0.37 | NURIX THERAPEUTI | BMVLGP2 | 15.40 | 6,388 | 147,345 |
0.35 | DAY ONE BIOPHARM | BLB0YH0 | 16.03 | 5,838 | 140,168 |
0.34 | RELAY THERAPEUTI | BN2R582 | 6.51 | 14,021 | 136,713 |
0.34 | FATE THERAPEUTIC | BCZS820 | 4.14 | 22,045 | 136,698 |
0.34 | ANAVEX LIFE SCIE | BYTYP72 | 4.50 | 20,241 | 136,426 |
0.33 | SUMMIT THERAPEUT | BMTVQS7 | 4.51 | 19,647 | 132,716 |
0.33 | REGENXBIO INC | BZ0G875 | 16.01 | 5,434 | 130,305 |
0.32 | OLEMA PHARMACEUT | BMZ4LN0 | 9.66 | 8,904 | 128,829 |
0.32 | KINIKSA PHARMA-A | BD0MGM0 | 20.11 | 4,256 | 128,193 |
0.31 | VERVE THERAPEUTI | BNKGXX2 | 6.38 | 13,039 | 124,599 |
0.27 | ALLOGENE THERAPE | BFZNYB7 | 3.01 | 23,739 | 107,024 |
0.26 | CULLINAN THERAPE | BM90J52 | 23.81 | 2,932 | 104,562 |
0.26 | ANAPTYSBIO INC | BDRW1L7 | 25.47 | 2,740 | 104,528 |
0.26 | MIMEDX GROUP INC | B1Z3TW5 | 7.89 | 8,709 | 102,919 |
0.22 | CARIBOU BIOSCIEN | BNYJR68 | 3.59 | 16,358 | 87,958 |
0.20 | MACROGENICS INC | BFDV8K0 | 5.12 | 10,656 | 81,718 |
0.19 | TANGO THERAPEUTI | BP2P6L0 | 7.79 | 6,647 | 77,556 |
0.17 | ALECTOR INC | BJ4LDC4 | 5.49 | 8,327 | 68,472 |
0.17 | ASTRIA THERAPEUT | BMYRFN8 | 9.43 | 4,729 | 66,793 |
0.12 | VOYAGER THERAPEU | BY7RB53 | 8.63 | 3,602 | 46,559 |
0.11 | CARGO THERAPEUTI | BQHN2F2 | 21.34 | 1,438 | 45,963 |
0.11 | ARS PHARMACEUTIC | BMCR7V2 | 9.10 | 3,371 | 45,946 |
0.11 | ORIC PHARMACEUTI | BKVDFF7 | 9.02 | 3,358 | 45,367 |
0.11 | MERSANA THERAPEU | BF3NP05 | 2.58 | 11,131 | 43,014 |
0.07 | SCILEX HOLDING C | BLKFRT9 | 0.87 | 21,910 | 28,550 |
0.05 | AVITA MEDICAL IN | BMX0JN6 | 7.92 | 1,559 | 18,494 |
Sector | Weight (%) | |
---|---|---|
Health Care | 99.8 | |
Other/Cash | 0.2 |
Country | Weight (%) | |
---|---|---|
United States | 97.4 | |
Ireland | 1.7 | |
Switzerland | 0.7 | |
Other/Cash | 0.2 |
Global X Management (AUS) Limited (“Global X”) (Australian Financial Services Licence Number 466778, ACN 150 433 828) is the product issuer. Offers of interests in any retail product will only be made in, or accompanied by, a Product Disclosure Statement (PDS). In respect of each retail product, Global X has prepared a target market determination (TMD). Each PDS and TMD is available at www.globalxetfs.com.au. The information on this website is general in nature only and does not take into account your personal objectives, financial situations or needs. Before acting on any information, you should consider the appropriateness of the information having regard to your objectives, financial situation or needs and consider seeking independent financial, legal, tax and other relevant advice having regard to your particular circumstances. Any investment decision should only be made after obtaining and considering the relevant PDS and TMD. Investments in any product issued by Global X are subject to investment risk, including possible delays in repayment and loss of income and principal invested. The value or return of an investment will fluctuate and an investor may lose some or all of their investment. Past performance is not a reliable indicator of future performance.